August 2024: The United States Food and Drug Administration (FDA) awarded fast approval late last week to the immunotherapy afamitresgene autoleucel (afami-cel) for the treatment of adults with synovi...
Dec 2022: Atezolizumab (Tecentriq, Genentech, Inc.) has been approved by the Food and Drug Administration (FDA) for adult and paediatric patients with unresectable or metastatic alveolar soft par...
Scientists at Michigan State University are designing a virus-like particle called Qβ, which will generate an anti-cancer immune response in the body and may be used as a new vaccine for cancer treat...
Scientists at Trinity College Dublin (TCD) have developed a new therapy that can help treat the most common rare soft tissue sarcoma affecting young people. Synovial sarcoma is a cancer that is diffi...
On October 19, 2016, the new drug Olaratumab passed the accelerated approval of the US FDA and could be combined with doxorubicin to treat specific types of soft tissue sarcoma (STS) in adults.portant...
George D. Demetri and others from the American Dana Fabre / Briegen and Women ’s Hospital Cancer Center reported that among patients with liposarcoma, the use of iriprine in the back-line treatment ...
What is sarcoma?Sarcoma is a rare connective tissue tumor, so sarcoma can invade any part of our body. These tumors include liposarcoma, neurosarcoma, osteosarcoma, tendon sarcoma, muscle and skin sa...
In September 2015, a child patient with rhabdomyosarcoma in Guangdong, China successfully completed proton radiotherapy at the Proton Center of the Eastern Hospital of the National Cancer Center in Ja...
On July 10, 2015, the National Cancer Institute (NCI) announced that the largest precision medicine clinical trial in history has begun to recruit patients. This experiment will recruit 1,000 cancer p...
Sarcoma, which occurs in young people and is a malignant tumor derived from mesenchymal tissue (including connective tissue and muscle). Sarcomas are highly malignant and develop rapidly! Common sar...